KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $35.86 $42.36 Thursday, 25th Apr 2024 CLDX stock ended at $36.26. This is 2.05% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.61% from a day low at $35.86 to a day high of $37.16.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Jun 08, 2021 $28.50 $29.83 $28.10 $29.65 645 033
Jun 07, 2021 $27.67 $28.96 $27.60 $28.50 746 392
Jun 04, 2021 $28.31 $28.70 $27.12 $27.91 203 918
Jun 03, 2021 $28.05 $28.76 $27.71 $28.07 240 957
Jun 02, 2021 $27.93 $28.16 $27.22 $28.01 488 357
Jun 01, 2021 $27.95 $28.34 $27.00 $27.78 286 677
May 28, 2021 $28.44 $29.24 $27.90 $27.95 234 477
May 27, 2021 $27.68 $28.27 $27.60 $28.25 426 953
May 26, 2021 $26.50 $27.54 $26.44 $27.54 263 047
May 25, 2021 $27.04 $27.48 $26.26 $26.39 296 714
May 24, 2021 $27.88 $28.11 $26.36 $26.87 335 700
May 21, 2021 $28.00 $28.08 $27.23 $27.52 272 128
May 20, 2021 $27.11 $27.85 $27.11 $27.65 370 863
May 19, 2021 $27.58 $27.85 $26.72 $27.00 247 659
May 18, 2021 $27.80 $28.28 $27.32 $27.55 278 745
May 17, 2021 $26.98 $27.90 $26.70 $27.38 284 359
May 14, 2021 $25.54 $27.11 $25.01 $27.09 302 590
May 13, 2021 $25.63 $26.44 $24.41 $25.01 341 589
May 12, 2021 $26.30 $27.00 $25.58 $25.59 320 417
May 11, 2021 $25.47 $27.61 $23.95 $26.77 288 089
May 10, 2021 $27.07 $27.54 $25.73 $26.49 310 589
May 07, 2021 $26.14 $27.37 $25.29 $27.31 553 482
May 06, 2021 $28.09 $28.09 $25.67 $26.57 499 282
May 05, 2021 $28.60 $29.46 $27.46 $27.68 507 569
May 04, 2021 $30.42 $30.70 $28.34 $28.50 476 082
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT